Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

Bayer’s Nexavar and Boehringer Ingelheim's Spiriva are among a handful of drugs with reduced US list prices for the new year, ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...